Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran
- PMID: 29420120
- PMCID: PMC6037465
- DOI: 10.1080/21645515.2018.1436920
Seroprevalence of antibodies to measles and rubella eight months after a vaccination campaign in the southeast of Iran
Abstract
Eight months after the mass immunization campaign of November 2015 against measles and rubella in the southeast of Iran, in order to evaluate the sero-immunity level of the people living in the mentioned region, a serosurvey study was performed. Using a multi-stage probability proportional to size cluster sampling, the sera of 1,056 participants, ranging from 15 months to 20 years old, were tested for measles and rubella IgG antibodies in the National Reference Laboratory at Tehran University of Medical Sciences, Tehran, Iran. The seroprevalence rates of antibodies against measles and rubella in the age groups below 16 years were respectively 98.4 and 93.2%. In the age group of 16 to 20 years, who was not the target of the mass immunization campaign, the said rates were respectively 91.7% and 87.4%. The herd immunity of the age groups below 16 years, who were the target of the campaign, is favourably high and reassuring both for measles and for rubella. Campaigns of supplementary vaccination play a substantial role for filling the gaps in the herd immunity.
Keywords: Herd immunity; Immunization; Iran; Measles; Rubella; Seroprevalence; Vaccination.
Similar articles
-
Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.BMC Infect Dis. 2021 Mar 25;21(1):305. doi: 10.1186/s12879-021-05970-7. BMC Infect Dis. 2021. PMID: 33765968 Free PMC article.
-
Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.BMC Infect Dis. 2024 Jul 12;24(1):696. doi: 10.1186/s12879-024-09593-6. BMC Infect Dis. 2024. PMID: 38997625 Free PMC article.
-
Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.Epidemiol Infect. 2013 Aug;141(8):1721-30. doi: 10.1017/S0950268812002130. Epub 2012 Sep 24. Epidemiol Infect. 2013. PMID: 22999024 Free PMC article.
-
Successes and challenges for preventing measles, mumps and rubella by vaccination.Curr Opin Virol. 2019 Feb;34:110-116. doi: 10.1016/j.coviro.2019.01.002. Epub 2019 Mar 7. Curr Opin Virol. 2019. PMID: 30852425 Review.
-
A 16-year review of seroprevalence studies on measles and rubella.Vaccine. 2016 Jul 29;34(35):4110-4118. doi: 10.1016/j.vaccine.2016.06.002. Epub 2016 Jun 20. Vaccine. 2016. PMID: 27340097 Review.
Cited by
-
Serosurvey of anti-rubella and anti-measles IgG antibodies in young females in Jahrom, southern west Iran in 2012: A review of literature of the serological profile in Iran.J Gen Fam Med. 2024 Feb 25;25(2):95-101. doi: 10.1002/jgf2.677. eCollection 2024 Mar. J Gen Fam Med. 2024. PMID: 38481743 Free PMC article.
-
Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran.BMC Infect Dis. 2021 Mar 25;21(1):305. doi: 10.1186/s12879-021-05970-7. BMC Infect Dis. 2021. PMID: 33765968 Free PMC article.
-
Estimation of measles risk using the World Health Organization Measles Programmatic Risk Assessment Tool, Iran.Heliyon. 2018 Nov 1;4(11):e00886. doi: 10.1016/j.heliyon.2018.e00886. eCollection 2018 Nov. Heliyon. 2018. PMID: 30417154 Free PMC article.
-
Reiteration of the elimination status of measles in the southeast of Iran, 2015.Hum Vaccin Immunother. 2018;14(12):2957-2963. doi: 10.1080/21645515.2018.1504537. Epub 2018 Sep 5. Hum Vaccin Immunother. 2018. PMID: 30085906 Free PMC article.
-
The spatial analysis of annual measles incidence and transition threat assessment in Iran in 2016.Med J Islam Repub Iran. 2019 Dec 4;33:130. doi: 10.34171/mjiri.33.130. eCollection 2019. Med J Islam Repub Iran. 2019. PMID: 32280636 Free PMC article.
References
-
- Personnaz D, Larson H. Iran and Turkey launch world's largest measles campaigns Geneva: Unicef; 2003; updated 9 December 2003 [accessed 2016 October 04] http://www.unicef.org/media/media_18172.html.
-
- Izadi S, Zahraie SM, Sartipi M. An investigation into a measles outbreak in southeast Iran. Jpn J Infect Dis. 2012;65(1):45–51. PMID:22274157. - PubMed
-
- Karimi A, Arjomandi A, Alborzi A, Rasouli M, Kadivar MR, Obood B, Pourabbas B. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran. East Mediterr Health J. 2004;10(4-5):468–73. PMID:16335636. - PubMed
-
- Immunization , Vaccination and Biologicals; Measles and Rubella Surveillance Data. World Health Organization; 2017; updated 11 September 2017 [accessed 2017 September 29] http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surve....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical